These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20815313)

  • 1. Anaphylactic reaction due to cyclopentolate in a 4-year-old child.
    Tayman C; Mete E; Catal F; Akca H
    J Investig Allergol Clin Immunol; 2010; 20(4):347-8. PubMed ID: 20815313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mydriaticum cyclopentolate induces severe allergy in a 5-year-old child.
    Diesner SC; Bannert C; Gruber S; Dehlink E; Eiwegger T; Szepfalusi Z
    Klin Padiatr; 2014 Jul; 226(4):252-3. PubMed ID: 25010132
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions.
    Jones LW; Hodes DT
    Ophthalmic Physiol Opt; 1991 Jan; 11(1):16-21. PubMed ID: 2034449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability to walk, disequilibrium, incoherent speech, disorientation following the instillation of 1% cyclopentolate eyedrops: case report.
    Derinoz O; Er A
    Pediatr Emerg Care; 2012 Jan; 28(1):59-60. PubMed ID: 22217890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclopentolate eye drops-induced anaphylaxis in an infant.
    Terece SP; Ertoy-Karagöl Hİ; Köken G; Atalay HT; Türkcan BT; Vural Ö; Bakırtaş A
    Turk J Pediatr; 2022; 64(5):915-918. PubMed ID: 36305442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric cycloplegia: a new approach.
    Shah P; Jacks AS; Adams GG
    Eye (Lond); 1997; 11 ( Pt 6)():845-6. PubMed ID: 9537142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLINICAL EVALUATION OF A NEW MYDRIATIC-MYDRILATE.
    Cowan EC; Archer D
    Br J Ophthalmol; 1962 Dec; 46(12):730-6. PubMed ID: 18170843
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic toxicity with cyclopentolate eye drops.
    Bhatia SS; Vidyashankar C; Sharma RK; Dubey AK
    Indian Pediatr; 2000 Mar; 37(3):329-31. PubMed ID: 10750080
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal necrotising enterocolitis due to mydriatic eye drops.
    Ozgun U; Demet T; Ozge KA; Zafer D; Murat S; Mehmet Y; Nilgun K
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S147-9. PubMed ID: 24906272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilation efficacy: is 1% cyclopentolate enough?
    Hug T; Olitsky S
    Optometry; 2007 Mar; 78(3):119-21. PubMed ID: 17321460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature.
    Mirshahi A; Kohnen T
    J Cataract Refract Surg; 2003 May; 29(5):1026-30. PubMed ID: 12781295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.
    Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M
    Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective comparison between cyclopentolate spray and drops in pediatric outpatients.
    Syrimi M; Jones SM; Thompson GM
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):290-5. PubMed ID: 23705592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The cycloplegic effect of atropine in comparison with the cyclopentolate-tropicamide-phenylephrine combination].
    Alimgil ML; Erda N
    Klin Monbl Augenheilkd; 1992 Jul; 201(1):9-11. PubMed ID: 1513131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niosomes as carriers for ophthalmic drugs: in vitro/in vivo evaluation.
    Perini G; Saettone MF; Carafa M; Santucci E; Alhaique F
    Boll Chim Farm; 1996 Feb; 135(2):145-6. PubMed ID: 8791827
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study.
    van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
    BMJ Open; 2015 Dec; 5(12):e008798. PubMed ID: 26700273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic contact dermatitis from cyclopentolate.
    Camarasa JG; Pla C
    Contact Dermatitis; 1996 Dec; 35(6):368-9. PubMed ID: 9118638
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with cycloplegic drops in German-speaking centers of pediatric ophthalmology and stabology--results of a 1999 survey].
    Barry JC; Loewen N
    Klin Monbl Augenheilkd; 2001 Jan; 218(1):26-30. PubMed ID: 11225396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epileptic seizures induced by cycloplegic eye drops.
    Wygnanski-Jaffe T; Nucci P; Goldchmit M; Mezer E
    Cutan Ocul Toxicol; 2014 Jun; 33(2):103-8. PubMed ID: 23815170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
    Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
    Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.